
Top Low-Debt Mid-Cap Stocks Compared: Caplin Point vs Grindwell Norton vs Fine Organic vs Dr Lal PathLabs vs Kansai Nerolac on Price, Valuation, Q2 FY27 Results and Risks
Previous close: Caplin Point Rs 2,346.80, Grindwell Norton Rs 1,844.70, Fine Organic Rs 5,277.00, Dr Lal PathLabs Rs 2,000.70, Kansai Nerolac Rs 197.94.
Updated: 17 Nov 2026 • 2:40 pm
Posted by:

Quick Answer
This low-debt mid-cap stocks compared snapshot checks five names on price, valuation and Q2 FY27 results: Caplin Point, Grindwell Norton, Fine Organic, Dr Lal PathLabs and Kansai Nerolac. Dr Lal PathLabs is the largest by market capitalisation at Rs 33,431 crore. Dr Lal PathLabs reports the highest return on equity at 21.32%. Low-debt mid-cap companies come from different industries, so read each multiple next to margins and returns.
Low-debt mid-cap stocks compared here means Caplin Point, Grindwell Norton, Fine Organic, Dr Lal PathLabs and Kansai Nerolac on one page, checked on previous close, market value, valuation and the latest quarterly numbers. The group covers a pharma exporter, an abrasives producer, a specialty additive maker, a diagnostics chain and a paint maker, so each name runs with little debt in a different industry, which is exactly why a side-by-side look helps.
All five companies have filed their September 2026 quarter, so every result below is Q2 FY27. Low-debt mid-cap stocks follow cash generation, margins and sector demand, so a glance at the Nifty Midcap 100 page and the Sensex page before you read the tables gives useful backdrop.
Click Here – Get Free Investment Predictions
Low-Debt Mid-Cap Stocks Compared: Five Names on the List
The low-debt mid-cap stocks compared here are Caplin Point, Grindwell Norton, Fine Organic, Dr Lal PathLabs and Kansai Nerolac. Dr Lal PathLabs is the largest by market capitalisation at Rs 33,431 crore. Previous closes run from Rs 197.94 for Kansai Nerolac to Rs 5,277.00 for Fine Organic, which is why a side-by-side look at value rather than price is more useful. This low-debt mid-cap stocks compared list is the base for every table that follows.
| Stock | Previous close (Rs) | Market cap (Rs crore) |
|---|---|---|
| Caplin Point | 2,346.80 | 18,155 |
| Grindwell Norton | 1,844.70 | 21,680 |
| Fine Organic | 5,277.00 | 16,299 |
| Dr Lal PathLabs | 2,000.70 | 33,431 |
| Kansai Nerolac | 197.94 | 16,258 |
A quick look at the business behind each ticker puts the numbers in context. Caplin Point makes and sells pharma products in Latin America and Africa, while Grindwell Norton makes abrasives and ceramics. Fine Organic makes oleochemical additives for food and plastics, and Dr Lal PathLabs runs diagnostic labs and collection centres. To compare low-debt mid-cap stocks properly, line up price to earnings, return on equity and debt to equity before forming a view.
Rounding out the group, Kansai Nerolac makes decorative and industrial paints. A fair low-debt mid-cap stock comparison looks at what each company actually earns from, not only at the share price. A services chain and a manufacturer belong in separate mental boxes whenever you compare low-debt mid-cap stocks fairly.
Low-Debt Mid-Cap Stocks Valuation: Multiples, Returns and Payouts
Caplin Point trades at the lowest price to earnings ratio in this group at 25.93. Dr Lal PathLabs reports the highest return on equity at 21.32%. Kansai Nerolac has the lowest price to book value at 2.36. These low-debt mid-cap stocks valuation readings come from the previous close and the latest reported financials. That is the idea behind this low-debt mid-cap stocks compared table: price to earnings and return on equity sit side by side so a high or low reading stands out at once.
| Stock | Price to earnings | Price to book | ROE (%) | Dividend yield (%) | Debt to equity |
|---|---|---|---|---|---|
| Caplin Point | 25.93 | 4.65 | 17.88 | 0.33 | 0.00 |
| Grindwell Norton | 46.79 | 8.34 | 17.76 | 0.97 | 0.02 |
| Fine Organic | 33.84 | 5.56 | 16.44 | 0.21 | 0.06 |
| Dr Lal PathLabs | 56.86 | 12.18 | 21.32 | 1.03 | 0.09 |
| Kansai Nerolac | 27.13 | 2.36 | 8.88 | 1.87 | 0.04 |
Price to earnings, return on equity, debt to equity and dividend yield give the clearest picture of valuation, returns and balance sheet room across the five names. Earnings per share and book value per share are the building blocks behind price to earnings and price to book, so a glance at both in each filing is time well spent. A simple low-debt mid-cap stock comparison like this one is only as useful as the context behind it, which is why debt to equity is worth checking as well.
In this group, price to earnings runs from 25.93 for Caplin Point to 56.86 for Dr Lal PathLabs. Kansai Nerolac offers the highest dividend yield at 1.87%. Industry price to earnings readings differ by sub-sector: Caplin Point at 40.55; Grindwell Norton at 42.97; Fine Organic at 33.54; Dr Lal PathLabs at 62.49; Kansai Nerolac at 45.18. The industry price to earnings is a handy anchor: a stock above it is priced for faster growth, and one below it is priced for steadier earnings. A well-built low-debt mid-cap stock comparison also notes that low debt does not replace a look at valuation. Run the same low-debt mid-cap stock comparison on your own watchlist and the pattern in these numbers will be easier to spot.
Low-Debt Mid-Cap Stocks Q2 FY27 Results: Revenue and Profit Check
All of the five low-debt mid-cap stocks compared have filed Q2 FY27 numbers. Fine Organic posted the fastest revenue growth at 22.9% year on year. Fine Organic showed the sharpest rise in net profit at 40.1%. Read revenue first and quarterly profit second, since the two together show how much of the growth reaches shareholders. Treat the Q2 FY27 numbers in this low-debt mid-cap stocks compared review as a snapshot of one quarter, not a verdict on any mid-cap company.
| Stock | Q2 FY27 revenue (Rs crore) | Q2 FY26 revenue (Rs crore) | Q2 FY27 net profit (Rs crore) | Q2 FY26 net profit (Rs crore) |
|---|---|---|---|---|
| Caplin Point | 663.1 | 564.4 | 182.3 | 160.2 |
| Grindwell Norton | 923.1 | 805.7 | 133.2 | 107.4 |
| Fine Organic | 760.0 | 618.4 | 152.1 | 108.5 |
| Dr Lal PathLabs | 908.2 | 755.4 | 193.9 | 152.2 |
| Kansai Nerolac | 2,352 | 1,983 | 144.0 | 133.3 |
Caplin Point Results Snapshot
Caplin Point reported Q2 FY27 revenue of Rs 663.1 crore, compared with Rs 564.4 crore a year earlier, a rise of 17.5%. Net profit rose 13.8% to Rs 182.3 crore from Rs 160.2 crore. Earnings per share for the quarter rose to Rs 23.37 from Rs 20.25.
Grindwell Norton Results Snapshot
In the September 2026 quarter, Grindwell Norton booked revenue of Rs 923.1 crore against Rs 805.7 crore in the same quarter last year, a rise of 14.6%. Net profit rose 24.0% to Rs 133.2 crore from Rs 107.4 crore. Operating margin expanded to 23.4% from 22.2% a year ago. Earnings per share for the quarter rose to Rs 11.99 from Rs 9.65.
Fine Organic Results Snapshot
Fine Organic's Q2 FY27 top line stood at Rs 760.0 crore, versus Rs 618.4 crore in Q2 FY26, a rise of 22.9%. Net profit rose 40.1% to Rs 152.1 crore from Rs 108.5 crore. Operating margin expanded to 29.2% from 26.0% a year ago. Earnings per share for the quarter rose to Rs 49.62 from Rs 35.40.
Dr Lal PathLabs Results Snapshot
Dr Lal PathLabs reported Q2 FY27 revenue of Rs 908.2 crore, compared with Rs 755.4 crore a year earlier, a rise of 20.2%. Net profit rose 27.4% to Rs 193.9 crore from Rs 152.2 crore. Operating margin expanded to 36.0% from 34.1% a year ago.
Kansai Nerolac Results Snapshot
In the September 2026 quarter, Kansai Nerolac booked revenue of Rs 2,352 crore against Rs 1,983 crore in the same quarter last year, a rise of 18.7%. Net profit rose 8.0% to Rs 144.0 crore from Rs 133.3 crore. Earnings per share for the quarter rose to Rs 1.81 from Rs 1.67.
Cash generation, margins and sector demand shape these stocks, and a light balance sheet adds room to grow, so profit can look different from revenue in a single quarter. That is why a low-debt mid-cap stock comparison works best when revenue and profit are read together across two or three quarters. Used this way, a low-debt mid-cap stocks compared review becomes a map of the sector rather than a price list. When you compare low-debt mid-cap stocks after each result season, track how debt to equity changes from one quarter to the next.
Low-Debt Mid-Cap Stocks Compared Two at a Time: Three Pairings
Readers rarely want a five-way table and nothing else, so here are three head-to-head reads drawn from the same data. Use them as a quick way to compare low-debt mid-cap stocks two at a time.
Caplin Point vs Fine Organic
Caplin Point and Fine Organic both run lean balance sheets with high margins. The two are close in size, with market capitalisations of Rs 18,155 crore for Caplin Point and Rs 16,299 crore for Fine Organic. On price to earnings, Caplin Point carries the lower multiple at 25.93 against 33.84 for Fine Organic. Caplin Point reports the higher return on equity, at 17.88% against 16.44% for Fine Organic. Two niche leaders, so read margins next to valuation.
Grindwell Norton vs Kansai Nerolac
Grindwell makes industrial abrasives, while Kansai Nerolac makes paints. On price to earnings, Kansai Nerolac carries the lower multiple at 27.13 against 46.79 for Grindwell Norton. Grindwell Norton reports the higher return on equity, at 17.76% against 8.88% for Kansai Nerolac. For dividend income, Kansai Nerolac offers 1.87% against 0.97% at Grindwell Norton. Two industrial suppliers with different customers, so compare returns first.
Dr Lal PathLabs vs Caplin Point
Dr Lal PathLabs runs diagnostic centres, while Caplin Point sells pharma products. Dr Lal PathLabs reports the higher return on equity, at 21.32% against 17.88% for Caplin Point. For dividend income, Dr Lal PathLabs offers 1.03% against 0.33% at Caplin Point. In Q2 FY27, Dr Lal PathLabs grew revenue faster, at 20.2% year on year against 17.5% for Caplin Point. A services chain and a product exporter follow different drivers.
Best Low-Debt Mid-Cap Stocks for Each Type of Investor
Which of the best low-debt mid-cap stocks is right for you depends on your priorities, so the table below lists the leader on each measure instead of crowning one name. Any low-debt mid-cap stocks compared table can mislead if you stop at one row, because each mid-cap company leads on a different measure.
| If you care most about | Start your research with | The number |
|---|---|---|
| Lowest price to earnings | Caplin Point | 25.93 |
| Highest return on equity | Dr Lal PathLabs | 21.32% |
| Highest dividend yield | Kansai Nerolac | 1.87% |
| Lowest price to book value | Kansai Nerolac | 2.36 |
| Largest by market capitalisation | Dr Lal PathLabs | Rs 33,431 crore |
| Fastest Q2 FY27 revenue growth | Fine Organic | 22.9% |
| Sharpest Q2 FY27 net profit rise | Fine Organic | 40.1% |
No single name tops every row, which is exactly why a low-debt mid-cap stock comparison helps. Balance sheets, margins and valuation point to different companies, so decide what matters most to you before you rank the numbers.
What Is Driving Low-Debt Mid-Cap Stocks Right Now?
Mid-sized companies with very little debt can fund growth from their own cash and keep interest costs low. Knowing what moves sector demand and cash generation helps you compare low-debt mid-cap stocks with the right questions in mind.
A strong balance sheet helps in slow phases, though valuation and growth still decide the outcome. A good low-debt mid-cap stocks compared routine therefore tracks cash generation, margins and capacity plans.
Risks to Weigh When You Compare Low-Debt Mid-Cap Stocks
Low-Debt Mid-Cap stocks depend on demand, input costs, policy and the wider market mood. Valuations differ by company, so read each filing for order, volume and margin commentary before you compare them. Every low-debt mid-cap stock comparison has blind spots, and for this group the biggest is sector demand and cash generation.
Because cash generation, margins and capacity plans drive these businesses, the most useful habit is to read the management commentary that comes with every result and note what is expected for the next quarter. Read together, the risk notes and the tables make this low-debt mid-cap stocks compared guide a balanced starting point.
How to Compare Low-Debt Mid-Cap Stocks and Build a Shortlist
Start by deciding which low debt business suits your view, because each reads the market differently. Readers who follow cash generation, margins and capacity plans find the group easier to track. Done step by step, this low-debt mid-cap stocks compared routine becomes repeatable rather than a one-off exercise.
Then check valuation and returns, because the five names rarely trade on the same multiple. A diagnostics chain next to an additive maker shows how the business behind each price changes the numbers. Keep the shortlist of best low-debt mid-cap stocks short enough that you can actually follow each company's quarterly results. When you compare low-debt mid-cap stocks again after new results, update only the rows that changed instead of starting over.
The Univest stock screener lets you filter low-debt mid-cap stocks by market capitalisation, return on equity and price to earnings, and the app keeps live prices a tap away through the trading day. Come back to this low-debt mid-cap stocks compared page after the next set of results to see which numbers have moved.
Check the Univest Screener for live low-debt mid-cap stock data
Download the Univest iOS App or Univest Android App to track these low-debt mid-cap stocks live.
Conclusion: Low-Debt Mid-Cap Stocks Compared at a Glance
This low-debt mid-cap stocks compared review on price, valuation and Q2 FY27 results shows that no single name wins every measure. Dr Lal PathLabs leads on both size and return on equity, though the others bring strengths of their own. Treat the low-debt mid-cap stocks Q2 FY27 results and low-debt mid-cap stocks valuation tables as a research starting point, then check the filings and speak to a SEBI-registered advisor before you invest. If you plan to compare low-debt mid-cap stocks again next quarter, the same checklist of price to earnings, return on equity and debt to equity will work.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Low-Debt Mid-Cap Stocks Compared
Which are the top low-debt mid-cap stocks compared in this article?
Ans. The low-debt mid-cap stocks compared in this article are Caplin Point, Grindwell Norton, Fine Organic, Dr Lal PathLabs and Kansai Nerolac. They are checked on previous close, market capitalisation, price to earnings, price to book, return on equity and the latest quarterly results, so the group can be read in one sitting before you go deeper into any single company.
Which low-debt mid-cap stock has the highest market capitalisation?
Ans. Among the five names, Dr Lal PathLabs has the highest market capitalisation at Rs 33,431 crore. Grindwell Norton follows at Rs 21,680 crore. Market value changes with every price move, which means the ranking can shuffle, so look at the latest figure on the exchange.
Which of these low-debt mid-cap stocks has the lowest price to earnings ratio?
Ans. On low-debt mid-cap stocks valuation, Caplin Point has the lowest price to earnings ratio among these low-debt mid-cap stocks at 25.93, based on the latest reported earnings. Dr Lal PathLabs sits at the other end at 56.86. Treat the lowest multiple as a place to start asking questions, because growth and business quality explain why investors pay more or less.
Which low-debt mid-cap stock has the highest return on equity?
Ans. Dr Lal PathLabs reports the highest return on equity in this group at 21.32%. In plain terms, return on equity tells you how hard shareholder funds are working. Read it across a few years and alongside debt, since a high ratio built on borrowing carries more risk.
How did low-debt mid-cap stocks perform in Q2 FY27 results?
Ans. All of the five names have filed Q2 FY27 numbers in our data. Fine Organic recorded the fastest revenue growth at 22.9% year on year. Fine Organic showed the sharpest net profit rise at 40.1%. For low-debt mid-cap stocks Q2 FY27 results, each filing on the exchange website carries the full detail behind these figures.
What are the main risks when you compare low-debt mid-cap stocks?
Ans. Low-Debt Mid-Cap stocks depend on demand, input costs, policy and the wider market mood. Valuations differ by company, so read each filing for order, volume and margin commentary before you compare them. Keep an eye on cash generation, margins and capacity plans.
Which metrics matter most when you compare Low-Debt Mid-Cap stocks?
Ans. Debt to equity, return on equity, operating margin and price to earnings matter most here. A light balance sheet is one factor, so read it next to growth and valuation. Read each filing for margin commentary.
Which is the best low-debt mid-cap stock to buy among these five?
Ans. The best Low-Debt Mid-Cap stock depends on which low debt business suits your view, because the five names differ on all of these. On the numbers in this article, Dr Lal PathLabs has the largest market capitalisation as well as the highest return on equity; Caplin Point has the lowest price to earnings; Kansai Nerolac has the highest dividend yield. There is no clear winner across every measure, and nothing here is a recommendation. Let the tables narrow your list, confirm the numbers in the filings, and take advice from a SEBI-registered advisor before acting.
Recent Articles

High Dividend Yield Stocks in India: Vedanta, Hindustan Zinc, Coal India and CESC Checked on 17 November 2026
17 November 2026

Top Mid-Cap Metal Stocks Compared: Jindal Stainless vs Gravita vs HEG vs Graphite India vs MOIL on Price, Valuation, Q2 FY27 Results and Risks
17 November 2026

Top Mid-Cap Hospital Stocks Compared: Rainbow Children vs HCG vs Jupiter Life Line vs KIMS vs Narayana Hrudayalaya on Price, Valuation, Q2 FY27 Results and Risks
17 November 2026

Top Mid-Cap Capital Goods Stocks Compared: Elgi Equipments vs GMM Pfaudler vs Grindwell Norton vs AIA Engineering vs Cummins India on Price, Valuation, Q2 FY27 Results and Risks
17 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
High Dividend Yield Stocks in India: Vedanta, Hindustan Zinc, Coal India and CESC Checked on 17 November 2026
Top Mid-Cap Metal Stocks Compared: Jindal Stainless vs Gravita vs HEG vs Graphite India vs MOIL on Price, Valuation, Q2 FY27 Results and Risks
Top Mid-Cap Hospital Stocks Compared: Rainbow Children vs HCG vs Jupiter Life Line vs KIMS vs Narayana Hrudayalaya on Price, Valuation, Q2 FY27 Results and Risks
Top Mid-Cap Capital Goods Stocks Compared: Elgi Equipments vs GMM Pfaudler vs Grindwell Norton vs AIA Engineering vs Cummins India on Price, Valuation, Q2 FY27 Results and Risks
Top Mid-Cap Auto Stocks Compared: Hyundai Motor India vs Force Motors vs JBM Auto vs Escorts Kubota vs Olectra on Price, Valuation, Q2 FY27 Results and Risks
Popular this week
Top Two-Wheeler Stocks Compared: Hero MotoCorp vs Bajaj Auto vs Eicher Motors vs TVS Motor vs Atul Auto on Price, Valuation, Q2 FY27 Results and Risks

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





